UBS Group’s LifeVantage LFVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $289K | Buy |
66,927
+47,749
| +249% | +$250K | ﹤0.01% | 6420 |
|
|
2025
Q4 | $118K | Buy |
19,178
+6,979
| +57% | +$51.7K | ﹤0.01% | 6826 |
|
|
2025
Q3 | $119K | Sell |
12,199
-11,504
| -49% | -$144K | ﹤0.01% | 7000 |
|
|
2025
Q2 | $310K | Buy |
23,703
+9,394
| +66% | +$121K | ﹤0.01% | 6412 |
|
|
2025
Q1 | $209K | Buy |
14,309
+13,603
| +1,927% | +$257K | ﹤0.01% | 6534 |
|
|
2024
Q4 | $12.4K | Buy |
706
+685
| +3,262% | +$9.6K | ﹤0.01% | 8197 |
|
|
2024
Q3 | $254 | Sell |
21
-1,769
| -99% | -$14.6K | ﹤0.01% | 9035 |
|
|
2024
Q2 | $11.5K | Buy |
1,790
+838
| +88% | +$5.68K | ﹤0.01% | 7635 |
|
|
2024
Q1 | $5.76K | Sell |
952
-688
| -42% | -$4.34K | ﹤0.01% | 7507 |
|
|
2023
Q4 | $9.84K | Sell |
1,640
-1,988
| -55% | -$13.1K | ﹤0.01% | 7467 |
|
|
2023
Q3 | $23.4K | Buy |
+3,628
| New | +$20.3K | ﹤0.01% | 6723 |
|
|
2023
Q2 | – | Sell |
-4,736
| Closed | -$17K | – | 9315 |
|
|
2023
Q1 | $17K | Buy |
4,736
+1,455
| +44% | +$5.46K | ﹤0.01% | 7201 |
|
|
2022
Q4 | $12.2K | Sell |
3,281
-2,879
| -47% | -$11K | ﹤0.01% | 8311 |
|
|
2022
Q3 | $23K | Buy |
6,160
+4,115
| +201% | +$16.7K | ﹤0.01% | 7206 |
|
|
2022
Q2 | $9K | Sell |
2,045
-611
| -23% | -$2.67K | ﹤0.01% | 8143 |
|
|
2022
Q1 | $12K | Sell |
2,656
-760
| -22% | -$4.22K | ﹤0.01% | 8189 |
|
|
2021
Q4 | $21K | Buy |
3,416
+2,525
| +283% | +$17.2K | ﹤0.01% | 7787 |
|
|
2021
Q3 | $6K | Sell |
891
-4,891
| -85% | -$36K | ﹤0.01% | 8429 |
|
|
2021
Q2 | $42K | Buy |
5,782
+288
| +5% | +$2.35K | ﹤0.01% | 6593 |
|
|
2021
Q1 | $51K | Buy |
5,494
+2,877
| +110% | +$26.8K | ﹤0.01% | 6521 |
|
|
2020
Q4 | $24K | Buy |
2,617
+1,897
| +263% | +$21.3K | ﹤0.01% | 6806 |
|
|
2020
Q3 | $9K | Sell |
720
-3,899
| -84% | -$52.7K | ﹤0.01% | 6935 |
|
|
2020
Q2 | $63K | Sell |
4,619
-3,620
| -44% | -$50.2K | ﹤0.01% | 5679 |
|
|
2020
Q1 | $84K | Sell |
8,239
-10,048
| -55% | -$138K | ﹤0.01% | 5438 |
|
|
2019
Q4 | $285K | Buy |
18,287
+4,727
| +35% | +$69.5K | ﹤0.01% | 5332 |
|
|
2019
Q3 | $186K | Buy |
13,560
+9,188
| +210% | +$112K | ﹤0.01% | 5299 |
|
|
2019
Q2 | $57K | Buy |
4,372
+2,781
| +175% | +$33.1K | ﹤0.01% | 5803 |
|
|
2019
Q1 | $22K | Sell |
1,591
-1,482
| -48% | -$21.5K | ﹤0.01% | 6227 |
|
|
2018
Q4 | $41K | Buy |
3,073
+1,518
| +98% | +$18.2K | ﹤0.01% | 6266 |
|
|
2018
Q3 | $17K | Buy |
1,555
+411
| +36% | +$4.38K | ﹤0.01% | 6890 |
|
|
2018
Q2 | $7K | Sell |
1,144
-1,821
| -61% | -$8.29K | ﹤0.01% | 7337 |
|
|
2018
Q1 | $10K | Sell |
2,965
-120
| -4% | -$509 | ﹤0.01% | 6864 |
|
|
2017
Q4 | $15K | Buy |
3,085
+2,013
| +188% | +$10.6K | ﹤0.01% | 6758 |
|
|
2017
Q3 | $5K | Sell |
1,072
-1,514
| -59% | -$5.93K | ﹤0.01% | 7220 |
|
|
2017
Q2 | $11K | Sell |
2,586
-4,958
| -66% | -$21.9K | ﹤0.01% | 6716 |
|
|
2017
Q1 | $40K | Buy |
7,544
+4,615
| +158% | +$29.1K | ﹤0.01% | 5681 |
|
|
2016
Q4 | $24K | Sell |
2,929
-1,423
| -33% | -$12.2K | ﹤0.01% | 6401 |
|
|
2016
Q3 | $41K | Buy |
4,352
+2,286
| +111% | +$29.7K | ﹤0.01% | 5678 |
|
|
2016
Q2 | $28K | Buy |
2,066
+286
| +16% | +$3.25K | ﹤0.01% | 6000 |
|
|
2016
Q1 | $16K | Sell |
1,780
-2,819
| -61% | -$25K | ﹤0.01% | 6357 |
|
|
2015
Q4 | $44K | Buy |
4,599
+921
| +25% | +$6.95K | ﹤0.01% | 5930 |
|
|
2015
Q3 | $21K | Sell |
3,678
-1,224
| -25% | -$5.87K | ﹤0.01% | 6640 |
|
|
2015
Q2 | $19K | Buy |
4,902
+2,693
| +122% | +$12.4K | ﹤0.01% | 6916 |
|
|
2015
Q1 | $12K | Sell |
2,209
-3,514
| -61% | -$25.3K | ﹤0.01% | 7490 |
|
|
2014
Q4 | $52K | Buy |
+5,723
| New | +$52.5K | ﹤0.01% | 6440 |
|
Other funds holding LFVN
CM
VCM
UBS Group's LFVN Position: Q1 2026 in Review
UBS Group increased its LifeVantage (LFVN) stake by 249% in Q1 2026, buying an estimated $250K and bringing the position to 66,927 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #6420.
UBS Group first reported a position in LFVN in Q4 2014 and has held it in 45 quarters since. The position peaked at $310K in Q2 2025. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.
- UBS Group held 66,927 shares of LifeVantage worth $289K as of Q1 2026.
- UBS Group bought 47,749 LifeVantage shares in Q1 2026, an estimated $250K.
- LifeVantage made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6420 holding.
- UBS Group first reported a position in LifeVantage in Q4 2014 and has held it in 45 quarters since.
- UBS Group's LifeVantage position peaked at $310K in Q2 2025.
- 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.